Target intelligence / Profile preview

Small RNA binding exonuclease protection factor La like 3 pseudogene (SSBL3P)

Target
SSBL3P
Molecular classification
Other (processed pseudogene)
01

Overview

Small RNA binding exonuclease protection factor La like 3 pseudogene (SSBL3P) is a genomic pseudogene resembling the functional SSB gene, which encodes the La autoantigen involved in RNA binding and protection[1]. As a pseudogene, SSBL3P is not believed to encode a functional protein product and is not considered a therapeutic target or functional molecule. Its sequence derives from but does not produce the Sjogren syndrome antigen B (La protein), known for RNA chaperone and exonuclease protection roles and as an autoantigen in autoimmune diseases. The functional SSB gene is involved in RNA metabolism and autoimmunity, but SSBL3P itself has no demonstrated biological function or disease association[1]. Key points and clarifications: - SSBL3P is specifically annotated as a pseudogene, meaning it does not produce a functional protein and has no direct role as an enzyme, receptor, transporter, or therapeutic target[1]. - The functional SSB gene should not be confused with SSBL3P; only the former encodes the clinically relevant La antigen[2][3][4][6]. - There is currently no evidence that SSBL3P acts as a therapeutic target, interacts with drugs, or serves as a biomarker. References: - [1] BioGPS entry for SSBL3P confirms its pseudogene status. - [2][3][4][6] Information about the functional SSB gene and La protein for context.

Other names
SSB like 3 pseudogeneSjogren syndrome antigen B pseudogenesmall RNA binding exonuclease protection factor La pseudogeneSSBL3P

Beyond the preview

Go deeper on Small RNA binding exonuclease protection factor La like 3 pseudogene (SSBL3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small RNA binding exonuclease protection factor La like 3 pseudogene (SSBL3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call